Agency Agreements in the Health Care Equipment & Supplies Industry
109 Contracts & Agreements
- Accelerate Diagnostics, Inc (1 contract)
- AIT Therapeutics, Inc. (1)
- Alphatec Holdings, Inc. (3)
- Arch Therapeutics, Inc. (1)
- Avinger Inc (1)
- BARRIER THERAPEUTICS INC (1)
- BIOLASE, INC (7)
- BIOLIFE SOLUTIONS INC (1)
- CESCA THERAPEUTICS INC. (2)
- Chelsea Therapeutics International, Ltd. (2)
- CHF Solutions, Inc. (10)
- Cytosorbents Corp (1)
- Danaher Corp. (2)
- DarioHealth Corp. (3)
- DELCATH SYSTEMS, INC. (3)
- EKSO BIONICS HOLDINGS, INC. (2)
- ENDOLOGIX INC (2)
- ESTABLISHMENT LABS HOLDINGS INC. (1)
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (1)
- GUIDED THERAPEUTICS INC (1)
- Hancock Jaffe Laboratories, Inc. (6)
- Heart Test Laboratories, Inc. (1)
- HELIUS MEDICAL TECHNOLOGIES, INC. (3)
- Innovative Eyewear Inc (1)
- InspireMD, Inc. (5)
- INVIVO THERAPEUTICS HOLDINGS CORP. (1)
- INVO Bioscience, Inc. (3)
- Medtronic plc (1)
- Microbot Medical Inc. (4)
- Motus GI Holdings, Inc. (3)
- MYOMO INC (3)
- Nemaura Medical Inc. (2)
- Neogen Corporation (1)
- OBALON THERAPEUTICS INC (1)
- PAVmed Inc. (4)
- Precision Therapeutics Inc. (4)
- REPROS THERAPEUTICS INC. (1)
- ReShape Lifesciences Inc. (1)
- SANUWAVE Health, Inc. (1)
- SECOND SIGHT MEDICAL PRODUCTS INC (2)
- Sintx Technologies, Inc. (4)
- Soliton, Inc. (2)
- STRATA Skin Sciences, Inc. (1)
- TearLab Corp (1)
- Tenon Medical, Inc. (1)
- Tivic Health Systems, Inc. (3)
- VERMILLION, INC. (2)
- Zimmer Biomet Holdings (1)
- Form of Placement Agency Agreement (Sintx Technologies, Inc., Filed With SEC on April 4, 2024)
- Form of Placement Agency Agreement (Sintx Technologies, Inc., Filed With SEC on March 26, 2024)
- Form of Placement Agency Agreement dated March 20, 2024, by and between Beyond Air, Inc. and Roth Capital Partners, LLC and Laidlaw & Company (UK) Ltd (AIT Therapeutics, Inc., Filed With SEC on March 22, 2024)
- Placement Agency Agreement (Glucose Biosensor Systems (Greater China) Holdings, Inc., Filed With SEC on March 13, 2024)
- Form of Placement Agency Agreement (CHF Solutions, Inc., Filed With SEC on March 13, 2024)
- Placement Agency Agreement dated March 1, 2024 (SECOND SIGHT MEDICAL PRODUCTS INC, Filed With SEC on March 5, 2024)
- Amendment No. 1 to Placement Agency Agreement dated January 31, 2024 (DarioHealth Corp., Filed With SEC on February 21, 2024)
- Placement Agency Agreement dated December 28, 2023 (DarioHealth Corp., Filed With SEC on February 21, 2024)
- Placement Agency Agreement, dated February 13, 2024, by and among BIOLASE, Inc., Lake Street Capital Markets, LLC and Maxim Group LLC (BIOLASE, INC, Filed With SEC on February 15, 2024)
- Form of Placement Agency Agreement by and among the Company, Lake Street Capital Markets, LLC and Maxim Group LLC (BIOLASE, INC, Filed With SEC on February 7, 2024)
- Form of Placement Agency Agreement (CHF Solutions, Inc., Filed With SEC on February 5, 2024)
- Form of Placement Agency Agreement (Sintx Technologies, Inc., Filed With SEC on February 2, 2024)
- Form of Placement Agency Agreement by and among the Company, Lake Street Capital Markets, LLC and Maxim Group LLC (BIOLASE, INC, Filed With SEC on January 31, 2024)
- Form of Placement Agency Agreement (CHF Solutions, Inc., Filed With SEC on January 31, 2024)
- Placement Agency Agreement dated January 24, 2024, by and between Aspira Womens Health Inc. and A.G.P./Alliance Global Partners (VERMILLION, INC., Filed With SEC on January 26, 2024)
- Placement Agency Agreement dated January 24, 2024, by and between Aspira Womens Health Inc. and A.G.P./Alliance Global Partners (VERMILLION, INC., Filed With SEC on January 25, 2024)
- Placement Agency Agreement, dated as of January 16, 2024, by and between Myomo, Inc. and A.G.P./Alliance Global Partners (MYOMO INC, Filed With SEC on January 17, 2024)
- Form of Placement Agency Agreement, between the Company and A.G.P (Motus GI Holdings, Inc., Filed With SEC on December 11, 2023)
- Placement Agency Agreement, dated December 6, 2023, by and among the Company and Maxim Group LLC (BIOLASE, INC, Filed With SEC on December 8, 2023)
- PIPE Placement Agency Agreement (Arch Therapeutics, Inc., Filed With SEC on November 9, 2023)
- Placement Agency Agreement dated as of October 12, 2023, by and between Nuwellis, Inc., Lake Street Capital Markets, LLC and Maxim Group LLC (CHF Solutions, Inc., Filed With SEC on October 17, 2023)
- Form of Placement Agency Agreement (Hancock Jaffe Laboratories, Inc., Filed With SEC on October 12, 2023)
- Form of Placement Agency Agreement by and between the Company, Lake Street Capital Markets, LLC and Maxim Group, LLC (CHF Solutions, Inc., Filed With SEC on September 29, 2023)
- Form of Placement Agency Agreement (OBALON THERAPEUTICS INC, Filed With SEC on September 12, 2023)
- Placement Agency Agreement, dated as of August 24, 2023, by and between Myomo, Inc. and A.G.P./Alliance Global Partners (MYOMO INC, Filed With SEC on August 28, 2023)
- Form of Placement Agency Agreement (BIOLASE, INC, Filed With SEC on August 14, 2023)
- Placement Agency Agreement, dated August 6, 2023, by and between Tivic Health Systems, Inc. and Maxim Group LLC (Tivic Health Systems, Inc., Filed With SEC on August 9, 2023)
- Placement Agency Agreement by and between the Company and the Placement Agent dated August 4, 2023 (INVO Bioscience, Inc., Filed With SEC on August 8, 2023)
- Form of Placement Agency Agreement (INVO Bioscience, Inc., Filed With SEC on July 31, 2023)
- Placement Agency Agreement, dated July 14, 2023, by and between Tivic Health Systems, Inc. and Maxim Group LLC (Tivic Health Systems, Inc., Filed With SEC on July 19, 2023)
- Placement Agency Agreement, dated July 10, 2023, by and between Tivic Health Systems, Inc. and Maxim Group LLC (Tivic Health Systems, Inc., Filed With SEC on July 11, 2023)
- Form of Placement Agency Agreement (Innovative Eyewear Inc, Filed With SEC on June 16, 2023)
- Form of Placement Agency Agreement (Tenon Medical, Inc., Filed With SEC on June 7, 2023)
- Form of Placement Agency Agreement by and between Heart Test Laboratories, Inc. and Maxim Group LLC, as exclusive placement agent thereunder (Heart Test Laboratories, Inc., Filed With SEC on June 7, 2023)
- Placement Agency Agreement by and between the Company and the Placement Agent dated March 23, 2023 (INVO Bioscience, Inc., Filed With SEC on March 28, 2023)
- Placement Agency Agreement by and between Myomo, Inc. and AGP/ Alliance Global Partners dated January 11, 2023 (MYOMO INC, Filed With SEC on January 13, 2023)
- Placement Agency Agreement dated as of August 5, 2022 by and between Helius Medical Technologies, Inc. and Roth Capital Partners, LLC (HELIUS MEDICAL TECHNOLOGIES, INC., Filed With SEC on August 9, 2022)
- Form of Placement Agency Agreement (HELIUS MEDICAL TECHNOLOGIES, INC., Filed With SEC on July 27, 2022)
- Placement Agency Agreement, dated June 27, 2022, by and among the Company and Maxim Group LLC (BIOLASE, INC, Filed With SEC on June 29, 2022)
- Form of Placement Agency Agreement (Hancock Jaffe Laboratories, Inc., Filed With SEC on September 8, 2021)
